The overall objective of the program project grant proposed in this application is to characterize the origin and pathophysiological role of inflammation in the course of early myocardial ischemia. Substantial experimental evidence supports the concept that localization of activated granulocyte contributes strongly to myocardial injury associated with ischemia and reperfusion. Evidence presented in the proposal gathered in our laboratories suggest that inflammatory events begin very early after the onset of myocardial ischemia. Our work suggest that molecules, released expression of cell surface adherence molecules which mediate leukocyte agreation and leukocyte adherence vascular endothelial cells and cardiac myocytes. The proposal addresses the following general objectives: A) Evaluate the time course and pathophysiological significance of the events involved in the development of inflammation in models of early myocardial ischemia as a function of extent and degree of ischemia. B) Identify and characterize tissue adherence molecules which mediate agreation, tissue adherence and transmigration of neutrophils in myocardial ischemia. C) Evaluate the role of reactive oxygen as an inflammatory stimulus itself as a catalyst in production of lipid derived leukotactic factors which may participate in initiation or modification of the inflammatory response. D) Identify, clone, and prepare antibody reagents to modify the reactivity of tissue adherence molecules in the endothelium an cardiac myocyte to which neutrophils adhere. E) Evaluate modifiers aimed to alter specific steps in the leukocyte inflammatory cascade. These modifying agents will be evaluated in vitro an in vivo for efficacy with respect to the specific step at which they are aimed and, subsequently, a potential therapeutic regimen may evolve.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Heart, Lung, and Blood Research Review Committee A (HLBA)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Baylor College of Medicine
Schools of Medicine
United States
Zip Code
Mann, Douglas L (2014) Colchicine and the failing heart: a ""FINER"" anti-inflammatory agent? JACC Heart Fail 2:138-40
Burns, Alan R; Phillips, Sharon C; Sokoya, Elke M (2012) Pannexin protein expression in the rat middle cerebral artery. J Vasc Res 49:101-10
Mann, Douglas L (2012) Sphingosine 1-phosphate as a therapeutic target in heart failure: more questions than answers. Circulation 125:2692-4
Hartley, Craig J; Reddy, Anilkumar K; Madala, Sridhar et al. (2011) Doppler velocity measurements from large and small arteries of mice. Am J Physiol Heart Circ Physiol 301:H269-78
Hartley, Craig J; Reddy, Anilkumar K; Madala, Sridhar et al. (2010) Feasibility of dual Doppler velocity measurements to estimate volume pulsations of an arterial segment. Ultrasound Med Biol 36:1169-75
Haudek, Sandra B; Gupta, Damon; Dewald, Oliver et al. (2009) Rho kinase-1 mediates cardiac fibrosis by regulating fibroblast precursor cell differentiation. Cardiovasc Res 83:511-8
Reddy, Anilkumar K; Namiranian, Khodidad; Lloyd, Eric E et al. (2009) Effect of isoflurane on aortic impedance in mice. Conf Proc IEEE Eng Med Biol Soc 2009:1104-5
Divakaran, Vijay; Adrogue, Julia; Ishiyama, Masakuni et al. (2009) Adaptive and maladptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading. Circ Heart Fail 2:633-42
Wu, Huaizhu; Gower, R Michael; Wang, Hong et al. (2009) Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia. Circulation 119:2708-17
Liu, Xiuping; Zuo, Yumei; Zhang, Weina et al. (2009) Expression of interleukin-15 and its receptor on the surface of stimulated human umbilical vein endothelial cells. J Huazhong Univ Sci Technolog Med Sci 29:527-34

Showing the most recent 10 out of 219 publications